Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: External pilot trial

Trials

Volumn 12, Issue , 2011, Pages

  Cooper, Cindy L ^a   Hind, Daniel ^a   Parry, Glenys D ^a   Isaac, Claire L ^b   Dimairo, Munyaradzi ^a   O'Cathain, Alicia ^a   Rose, Anita ^c   Freeman, Jennifer V ^a   Martin, Leonie ^a   Kaltenthaler, Eva C ^a   Thake, Anna ^a   Sharrack, Basil ^d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; COGNITIVE THERAPY; COMPUTERIZED COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DEPRESSION; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; OUTPATIENT CARE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT OUTCOME; UNITED KINGDOM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INFORMATION PROCESSING; MIDDLE AGED; PATIENT SELECTION; PILOT STUDY; SAMPLE SIZE;

ADULT; COGNITIVE THERAPY; DATA COLLECTION; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PATIENT SELECTION; PILOT PROJECTS; SAMPLE SIZE;

EID: 83355161425     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-259     Document Type: Article

References (37)

1. Sadovnick AD, Dyment DA, Ebers GC, Risch NJ, . the Canadian Collaborative Study Group Evidence for genetic basis of multiple sclerosis. The Lancet 1996, 347:1728-1730. the Canadian Collaborative Study Group.
2. Sharrack B, Hughes RAC. Scale development and Guy's Neurological Disability Scale. Journal of Neurology 1999, 246:226. 10.1007/s004150050340, 10323324.
3. Confavreux C, Compston A. The natural history of multiple sclerosis. McAlpine's Multiple Sclerosis 2006, 183-272. London: Elsevier, Compston A, 4.
4. Benito-León J, Manuel Morales J, Rivera-Navarro J, Mitchell AJ. A review about the impact of multiple sclerosis on health-related quality of life. Disability & Rehabilitation 2003, 25:1291-1303. 10.1080/09638280310001608591, 22228617.
5. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005, 76:469-475. 10.1136/jnnp.2004.054635, 1739575, 15774430.
6. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database of Systematic Reviews 2006, (1). Art. No.: CD004431 DOI: 10.1002/14651858.CD004431.pub2.
7. Layard R. The case for psychological treatment centres. BMJ 2006, 332:1030-1032. 10.1136/bmj.332.7548.1030, 1450056, 16644834.
8. National Collaborating Centre for Mental Health Depression: Management of depression in primary and secondary care (National Clinical Practice Guideline Number 23). 2008, London, National Institute for Health and Clinical Excellence, Ref Type: Report, National Collaborating Centre for Mental Health.
9. Seymour L, Grove B. Workplace Interventions for People with Common Mental Health Problems. 2005, London, British Occupational Health Research Foundation, Ref Type: Report.
10. . Care Services Improvement Partnership, Primary Care Services for Depression A guide to best practice. 2006, London, Department of Health, Ref Type: Report, Care Services Improvement Partnership, Primary Care Services for Depression.
11. . National Institute for Health and Clinical Excellence, Technology Appraisal 97 Computerised cognitive behavioural therapy for depression and anxiety. Review of Technology Appraisal 51 2006, London, NICE, Ref Type: Report, National Institute for Health and Clinical Excellence, Technology Appraisal 97.
12. Creed F. Assessing depression in the context of physical illness. Perspectives in Psychiatry Volume 6: Depression and Physical Illness 1997, 3-19. Baffins Lane, England: John Wiley, Robertson MM, Katona CLE.
13. National Collaborating Centre for Mental Health Depression in adults with a chronic physical health problem: Treatment and management. NICE Clinical Guideline 91 2009, London, National Institute for Health and Clinical Excellence, National Collaborating Centre for Mental Health.
14. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, Guthrie B, Lester H, Wilson P, Kinmouth AL. Designing and evaluating complex interventions to improve health care. BMJ 2007, 334:455-459. 10.1136/bmj.39108.379965.BE, 1808182, 17332585.
15. Hind D, O'Cathain A, Cooper CL, Parry GD, Isaac CL, Rose A, Martin L, Lharrack B. The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: A qualitative study of people with multiple sclerosis. Psychology & Health 2010, 25:699-712. 10.1080/08870440902842739, 3250642, 22229089.
16. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios L, Robson R, Thabane M, Giangregorio L, Loldsmith CH. A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology 2010, 10:1. 10.1186/1471-2288-10-1, 2824145, 20053272.
17. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman DA, Moher D. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 337.
18. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatients. Journal of Personality Assessment 1996, 67:588-597. 10.1207/s15327752jpa6703_13, 8991972.
19. Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L, Lublin F, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ldquoMcDonald Criteriardquo. Annals of Neurology 2005, 58:840-846. 10.1002/ana.20703, 16283615.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198. 10.1016/0022-3956(75)90026-6, 1202204.
21. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
22. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59:22-33.
23. Hobart JC, Riazi A, Lamping D, Fitzpatrick R, Thompson AJ. Hobart JCImproving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004, 8:iii. 1-48.
24. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992, 305:160-164. 10.1136/bmj.305.6846.160, 1883187, 1285753.
25. Spitzer RL, Kroenke K, Williams JBW, . and the Patient Health Questionnaire Primary Care Study Group Validation and Utility of a Self-report Version of PRIME-MD: The PHQ Primary Care Study. JAMA: The Journal of the American Medical Association 1999, 282:1737-1744. and the Patient Health Questionnaire Primary Care Study Group.
26. Spitzer RL, Kroenke K, Williams JBW, Lowe B. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Arch Intern Med 2006, 166:1092-1097. 10.1001/archinte.166.10.1092, 16717171.
27. Julious SA. Sample Size Of 12 Per Group Rule Of Thumb For A Pilot Study. Pharmaceutical Statistics 2005, 4:287-291.
28. Mohr DC, Boudewyn AC, Goodkin DE, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001, 69:942-949.
29. Cohen J. Statistical power analysis and for the behavioral sciences 1988, Hillsdale (NJ): Erlbaum.
30. Kaltenthaler E, Sutcliffe P, Parry G, Beverley C, Rees A, Ferriter M. The acceptability to patients of computerized cognitive behaviour therapy for depression: a systematic review. Psychological Medicine 2008, 38:1521-1530. 10.1017/S0033291707002607, 18205964.
31. Aikens JE, Reinecke MA, Pliskin NH, Fischer JS, Wiebe JS, McCracken LM, Maylor JL. Assessing depressive symptoms in multiple sclerosis: is it necessary to omit items from the original Beck Depression Inventory?. Journal of Behavioral Medicine 1999, 22(2):127-42. 10.1023/A:1018731415172, 10374139.
32. Moran PJ, Mohr DC. The Validity of Beck Depression Inventory and Hamilton Rating Scale for Depression Items in the Assessment of Depression Among Patients with Multiple Sclerosis. Journal of Behavioral Medicine 2005, 28:35-41. 10.1007/s10865-005-2561-0, 15887874.
33. House A. Mood Disorders in the physically ill. Problems of definition and measurement. Journal of Psychosomatic Research 1988, 32(4/5):345-353.
34. Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, Cooper R, Felix LM, Pratap S. Methods to increase response to postal and electronic questionnaires. Cochrane Database Systematic Review Database 2009, (3).
35. Sollom AC, Kneebone II. Treatment of depression in people who have multiple sclerosis. Multiple Sclerosis 2007, 13:632-635. 10.1177/1352458507072384, 17548443.
36. Cuijpers P, van Straten A, van Schaik A, Andersson G. Psychological treatment of depression in primary care: a meta-analysis. British Journal of General Practice 59:e51-e60.
37. Moss-Morris R, Dennison L, Yardley L, Landau S, Roche S, McCrone P, Chalder T. Protocol for the saMS trial (supportive adjustment for multiple sclerosis): a randomized controlled trial comparing cognitive behavioral therapy to supportive listening for adjustment to multiple sclerosis. BMC Neurology 2009, 9:45. 10.1186/1471-2377-9-45, 3224733, 19698171.